ARLINGTON, VA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)IDSA EDUCATION AND RESEARCH FOUNDATION, founded in 2001, is a community nonprofit in the Health Care sector that reported $2.0M in total revenue in fiscal year 2024. Revenue fell 30% from the prior year — a significant decline worth monitoring.
THE IDSA FOUNDATION, THE 501(C)(3) CHARITABLE ARM OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA, COMPLEMENTS IDSA'S MISSION BY SECURING PHILANTHROPIC AND INDUSTRY SUPPORT TO ADVANCE ITS STRATEGIC PRIORITIES. THE FOUNDATION STRENGTHENS THE INFECTIOUS DISEASES WORKFORCE, PROMOTES INCLUSION AND EQUITY, AND EXPANDS IDSA'S CAPACITY TO LEAD IN RESEARCH, PREPAREDNESS, AND PUBLIC HEALTH RESPONSEENSURING LASTING IMPACT IN THE FIGHT AGAINST INFECTIOUS DISEASES.
THE MICROBIAL PATHOGENESIS IN ALZHEIMER'S DISEASE PROGRAM (ALZ/ID) WAS LAUNCHED TO SUPPORT INNOVATIVERESEARCH THAT MAY LINK INFECTIOUS DISEASES AND ALZHEIMER'S DISEASE. THIS RESEARCH INCLUDES...
THE MICROBIAL PATHOGENESIS IN ALZHEIMER'S DISEASE PROGRAM (ALZ/ID) WAS LAUNCHED TO SUPPORT INNOVATIVERESEARCH THAT MAY LINK INFECTIOUS DISEASES AND ALZHEIMER'S DISEASE. THIS RESEARCH INCLUDES BASIC,CLINICAL AND/OR NON-TRADITIONAL RESEARCH APPROACHES ACROSS A WIDE RANGE OF DISCIPLINES INCLUDING NEUROLOGY, MICROBIOLOGY, PATHOLOGY, VIROLOGY, AND BACTERIOLOGY. IN 2022, IDSA FOUNDATION RECEIVED GRANTS TOTALING $3.3 MILLION TO FUND RESEARCH AWARDS FOR THIS PROGRAM. IN 2023, AWARDS OF APPROXIMATELY $2.5 MILLION WERE GRANTED TO RESEARCHERS, IN ADDITION TO OTHER INCURRED EXPENSES RELATED TO THE PROGRAM. DUE TO THE REQUIREMENTS OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (GAAP), THE TIMING OF THE REVENUE AND EXPENSE RECOGNITION CREATED A LARGE SURPLUS IN 2022 AND A LARGE DEFICIT IN 2023. IN 2023, THE PROGRAM LAUNCHED THE FIRST MICROBIAL PATHOGENESIS IN ALZHEIMER'S DISEASE SYMPOSIUM, PROVIDED ONGOING ASSISTANCE AND MONITORING FOR EXISTING GRANTEES. NO ADDITIONAL GRANTS WERE ISSUED IN 2024, ALTHOUGH ADDITIONAL FUNDS ARE AVAILABLE FOR GRANTS IN 2025.
G.E.R.M.GERM - THE GERM PROGRAM WAS DEVELOPED TO PROVIDE MEDICAL STUDENTS WITH MENTORED CLINICAL LEARNINGAND/OR RESEARCH EXPERIENCE IN INFECTIOUS DISEASES-RELATED TOPICS, INCLUDING HIV. IN 2024, 75...
G.E.R.M.GERM - THE GERM PROGRAM WAS DEVELOPED TO PROVIDE MEDICAL STUDENTS WITH MENTORED CLINICAL LEARNINGAND/OR RESEARCH EXPERIENCE IN INFECTIOUS DISEASES-RELATED TOPICS, INCLUDING HIV. IN 2024, 75 PEOPLE APPLIED TO THE GERM PROGRAM AND 40 $4,000 GRANTS WERE AWARDED TOTALING $160,000. THE GOAL OF THE G.E.R.M. PROGRAM IS TO INCREASE INTEREST AMONG UNDERGRADUATE MEDICAL STUDENTS, PARTICULARLY AMONG POPULATIONS UNDERREPRESENTED IN MEDICINE, IN PURSUING ID FELLOWSHIP POST-GRADUATE TRAINING OR A CAREER IN HIV MEDICINE BY PROVIDING MENTOR-BASED RESEARCH OR CLINICAL TRAINING; IMPROVING ANALYTIC, RESEARCH AND CLINICAL SKILLS OF MEDICAL STUDENTS; INCREASING THE NUMBER AND DIVERSITY OF THE ID/HIV RESEARCH AND CLINICAL WORKFORCE. ELIGIBLE APPLICANTS INCLUDED FIRST-, SECOND-, AND THIRD YEAR MEDICAL STUDENTS AND THOSE IN COMBINED DEGREE PROGRAMS (MD/MPH, MD/PHD) FROM ACCREDITED ALLOPATHIC OR OSTEOPATHIC MEDICAL SCHOOLS IN THE U.S. APPLICATIONS WERE REVIEWED AND SCORED BY AN EXPERT PANEL OF INFECTIOUS DISEASE SPECIALISTS.
HIV CLINICAL FELLOWSHIP PROGRAMHIV CLINICAL FELLOWSHIP PROGRAM - THE GOAL OF THE HIV CLINICAL FELLOWSHIP PROGRAM IS TO PROVIDE NON-ID TRAINED PHYSICIANS WITH THE MOST UPDATED BEST PRACTICES FOR...
HIV CLINICAL FELLOWSHIP PROGRAMHIV CLINICAL FELLOWSHIP PROGRAM - THE GOAL OF THE HIV CLINICAL FELLOWSHIP PROGRAM IS TO PROVIDE NON-ID TRAINED PHYSICIANS WITH THE MOST UPDATED BEST PRACTICES FOR TREATING PATIENTS LIVING WITH HIV. CLINICAL TRAINING INCLUDES MANAGEMENT OF ANTIRETROVIRAL THERAPY, TREATING COMMON CO-INFECTIOUS AND COMORBIDITIES AND MULTIDISCIPLINARY TEAM-BASED CARE. FELLOWS ARE SUPPORTED FOR UP TO TWO YEARS DURING WHICH TIME THEY MANAGE THE CARE OF A MINIMUM OF 30 PATIENTS, UNDER THE SUPERVISION OF AN HIV MEDICAL ASSOCIATION MENTOR. IN 2024, ONE FELLOW WAS FUNDED WITH A $120,436 AWARD.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,955,500 | $2,808,763 | -0.3% |
| Expenses | $2,074,376 | $5,200,883 | -0.6% |
| Net Income | $-118,876 | $-2,392,120 | -1.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| AMANDA GIANINO | VICE PRESIDENT, BUSINESS DEVELOPMENT | 37.50 |
Highest
|
$176,959 | $14,760 | $191,719 |
| TY JOHNSON | CHIEF OPERATING OFFICER | 12.50 |
Officer
|
$104,406 | $39,915 | $470,589 |
| CHRISTOPHER BUSKY CAE | CHIEF EXECUTIVE OFFICER | 1.00 |
Officer
|
$15,664 | $86,330 | $813,135 |
| BARTON GROH | VP, FINANCE AND ADMINISTRATION | 1.00 |
Officer
|
$11,945 | $47,706 | $283,621 |
| ANDREA WEDDLE | ED, HIVMA | 1.00 |
Key Emp
|
$6,374 | $33,546 | $278,957 |
| SALANDRA THOMAS | VP, TALENT AND ORG. DEVELOPMENT | 1.00 |
Highest
|
$6,090 | $46,179 | $280,649 |
| TINA TAN MD | CHAIR UNTIL 10/24 | 1.00 |
Director
|
$0 | $0 | $0 |
| RONALD NAHASS MD | DIR. UNTIL 10/24, CHAIR AFTER 10/24 | 1.00 |
Director
|
$0 | $0 | $0 |
| WENDY ARMSTRONG MD | VICE CHAIR AS OF 10/24 | 1.00 |
Director
|
$0 | $0 | $0 |
| MAXIMO BRITO MD | SECRETARY & TREASURER | 1.00 |
Director
|
$0 | $0 | $0 |
| RANA CHAKRABORTY MD | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| JASMINE MARCELIN MD | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $1,955,500 | $2,074,376 | $952,034 | $-118,876 |
| 2023 | $2,808,763 | $5,200,883 | $956,565 | $-2,392,120 |
| 2022 | $6,109,828 | $3,927,176 | $3,202,718 | $2,182,652 |
| 2021 | $4,528,287 | $3,972,964 | $3,203,937 | $555,323 |
| 2020 | $3,271,342 | $2,651,512 | $709,189 | $619,830 |
| 2019 | $1,705,853 | $1,888,188 | $1,066,305 | $-182,335 |
| 2018 | $2,095,480 | $1,602,705 | $911,467 | $492,775 |
Compare IDSA EDUCATION AND RESEARCH FOUNDATION with other nonprofits in Virginia and across the country.